Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Myeloprotection"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bogdan I. Gerashchenko, Veronika V. Sarnatskaya, Kvitoslava I. Bardakhivska, Oleksii S. Sydorenko, Denis L. Kolesnik, Dmytro O. Klymchuk
Publikováno v:
Heliyon, Vol 9, Iss 7, Pp e18414- (2023)
Chemotherapy can often cause a variety of side effects including bone marrow (BM) suppression, termed as myelosuppression. Accordingly, facile and effective management of chemotherapy-induced myelosuppression is currently a pivotal task for experimen
Externí odkaz:
https://doaj.org/article/b9afdd9405a44c83af30bc53a81ec66f
Autor:
Hussein M, Maglakelidze M, Richards DA, Sabatini M, Gersten TA, Lerro K, Sinielnikov I, Spira A, Pritchett Y, Antal JM, Malik R, Beck JT
Publikováno v:
Cancer Management and Research, Vol Volume 13, Pp 6207-6218 (2021)
Maen Hussein,1 Marina Maglakelidze,2 Donald A Richards,3 Marielle Sabatini,4 Todd A Gersten,5 Keith Lerro,6 Ivan Sinielnikov,7 Alexander Spira,8,9 Yili Pritchett,10 Joyce M Antal,10 Rajesh Malik,10 J Thaddeus Beck11 1Florida Cancer Specialists, Leesb
Externí odkaz:
https://doaj.org/article/6ad376d1d96c4525a27e9e55ccf55cb8
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Chemotherapy-induced damage of hematopoietic stem and progenitor cells (HPSCs) often results in myelosuppression that adversely affects patient health and quality of life. Currently, chemotherapy-induced myelosuppression is managed with chemotherapy
Externí odkaz:
https://doaj.org/article/57b7357bb52c4c438749d10bbd35e9e6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Manuel Dómine Gómez, Tibor Csőszi, Rajesh K. Malik, Krasimir Nikolov, Iveta Kudaba, Davorin Radosavljevic, Jana Jaal, Janet K. Horton, Jie Xiao, Janakiraman Subramanian
Publikováno v:
International Journal of Cancer
Chemotherapy-induced myelosuppression is an acute, dose-limiting toxicity of chemotherapy regimens used in the treatment of extensive-stage small cell lung cancer (ES-SCLC). Trilaciclib protects haematopoietic stem and progenitor cells from chemother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::397a1ab260b5397a4563aa20f7c067be
http://europepmc.org/articles/PMC8457063
http://europepmc.org/articles/PMC8457063
Autor:
Donald A. Richards, J. Thaddeus Beck, Rajesh K. Malik, Joyce M Antal, Ivan Sinielnikov, Keith Lerro, Marielle Sabatini, Maen A. Hussein, Marina Maglakelidze, Alexander I. Spira, Todd A Gersten, Yili Pritchett
Publikováno v:
Cancer Management and Research
Maen Hussein,1 Marina Maglakelidze,2 Donald A Richards,3 Marielle Sabatini,4 Todd A Gersten,5 Keith Lerro,6 Ivan Sinielnikov,7 Alexander Spira,8,9 Yili Pritchett,10 Joyce M Antal,10 Rajesh Malik,10 J Thaddeus Beck11 1Florida Cancer Specialists, Leesb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::302a79f6b1f9ddbdbd908703851c2717
https://www.dovepress.com/myeloprotective-effects-of-trilaciclib-among-patients-with-small-cell--peer-reviewed-fulltext-article-CMAR
https://www.dovepress.com/myeloprotective-effects-of-trilaciclib-among-patients-with-small-cell--peer-reviewed-fulltext-article-CMAR
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
Chemotherapy-induced damage of hematopoietic stem and progenitor cells (HPSCs) often results in myelosuppression that adversely affects patient health and quality of life. Currently, chemotherapy-induced myelosuppression is managed with chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83dfc9c14ad00663349c413182073609
https://pubmed.ncbi.nlm.nih.gov/34307165
https://pubmed.ncbi.nlm.nih.gov/34307165
Autor:
Jasnic Nebojsa, Mitić-Ćulafić Dragana, Simin Nataša, Nikolić Biljana, Knežević-Vukčević Jelena, Pavić Aleksandar, Vasiljević Branka
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 109, Iss, Pp 2482-2491 (2019)
The objective of this study was to evaluate potential of two chemically characterized edible wild onion species, Allium flavum and Allium carinatum, to reduce side effects of cytostatic doxorubicin (Dox). Since Dox application is mainly limited due t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3eec498f1ff267e05e9f5c57f910b5ba
http://www.sciencedirect.com/science/article/pii/S0753332218368070
http://www.sciencedirect.com/science/article/pii/S0753332218368070